University of Cape Coast Institutional Repository

African Lettuce (Launaea taraxacifolia) Displays Possible Anticancer Effects and Herb–Drug Interaction Potential by CYP1A2, CYP2C9, and CYP2C19 Inhibition

Show simple item record

dc.contributor.author Thomford, Nicholas E.
dc.contributor.author Mkhize, Buyisile
dc.contributor.author Dzobo, Kevin
dc.contributor.author Mpye, Keleabetswe
dc.contributor.author Rowe, Arielle
dc.contributor.author Parker, M. Iqbal
dc.contributor.author Wonkam, Ambroise
dc.contributor.author Skelton, Michelle
dc.contributor.author September, Alison V
dc.date.accessioned 2023-10-05T17:32:23Z
dc.date.available 2023-10-05T17:32:23Z
dc.date.issued 2016
dc.identifier.uri http://hdl.handle.net/123456789/9100
dc.description.abstract Medicinal plants are part of the healthcare systems worldwide, especially in low- and middle-income countries. African lettuce (Launaea taraxacifolia) is cultivated extensively in Africa, from Senegal in the west to Ethiopia and Tanzania in the east, and in Southern Africa. Potential anticancer effects of L. taraxacifolia have been suggested, but little is known about putative molecular mechanisms or potential for herb–drug interactions through inhibition or induction of drug-metabolizing enzymes. We investigated the effects of crude aqueous extracts of L. taraxacifolia on growth kinetics and cell cycle progression of the WHC01 esophageal cancer cells. Antiproliferative and apoptotic effects were evaluated using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide] assay and flow cytometry, while examining, in parallel, the genes regulating apoptosis and cell cycle in this cell culture model. In addition, we tested the inhibitory and enzyme kinetic effects of the aqueous L. taraxacifolia using recombinant human CYP450 isozyme model systems (CYP1A2, CYP2C9, and CYP2C19). L. taraxacifolia exhibited a significant growth inhibitory effect on the WHC01 cancer cells. Most cell cycle genes were downregulated. Cell cycle analysis showed a G0-G1 cell cycle arrest in WHC01 cells in the presence of L. taraxacifolia extract, accompanied by morphological changes. L. tarax- acifolia extract treatment resulted in downregulation of expression levels of CYP1A2 ( p < 0.0005) and CYP2C19 ( p < 0.003) by 50–70%. L. taraxacifolia extract caused reversible and time-dependent inhibition of the recombinant CYP1A2, CYP2C9, and CYP2C19. This study provides new insights on possible anticancer effects of L. taraxacifolia, a widely used medicinal plant in parts of Africa and across the world especially by patients with cancer. Further mechanistic studies expanding on these observations would be timely and con- tribute to the field of global precision medicine that requires solid understanding of drug and herb molecular mechanisms of action and drug–herb interaction potentials, given the worldwide use of medicinal plants. en_US
dc.language.iso en en_US
dc.publisher OMICS A Journal of Integrative Biology en_US
dc.title African Lettuce (Launaea taraxacifolia) Displays Possible Anticancer Effects and Herb–Drug Interaction Potential by CYP1A2, CYP2C9, and CYP2C19 Inhibition en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account